Hancox, J. C., Melgari, D., Dempsey, C. E., Brack, K. E., Mitcheson, J., & Ng, G. A. (2015). hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes. Ther Adv Drug Saf.
Citação norma ChicagoHancox, Jules C., Dario Melgari, Christopher E. Dempsey, Kieran E. Brack, John Mitcheson, and G. André Ng. "HERG Potassium Channel Inhibition By Ivabradine May Contribute to QT Prolongation and Risk of Torsades De Pointes." Ther Adv Drug Saf 2015.
Citação norma MLAHancox, Jules C., et al. "HERG Potassium Channel Inhibition By Ivabradine May Contribute to QT Prolongation and Risk of Torsades De Pointes." Ther Adv Drug Saf 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.